A stock that deserves closer examination: e.l.f. Beauty Inc (ELF)

While e.l.f. Beauty Inc has underperformed by -2.65%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ELF fell by -36.54%, with highs and lows ranging from $219.77 to $49.40, whereas the simple moving average jumped by 23.38% in the last 200 days.

On February 07, 2025, UBS Downgraded e.l.f. Beauty Inc (NYSE: ELF) to Neutral. A report published by Morgan Stanley on February 07, 2025, Downgraded its rating to ‘Equal-Weight’ for ELF. DA Davidson also Downgraded ELF shares as ‘Neutral’, setting a target price of $80 on the company’s shares in a report dated February 07, 2025. Morgan Stanley January 13, 2025d the rating to Overweight on January 13, 2025, and set its price target from $139 to $153. Goldman initiated its ‘Buy’ rating for ELF, as published in its report on December 13, 2024. Deutsche Bank’s report from December 12, 2024 suggests a price prediction of $133 for ELF shares, giving the stock a ‘Hold’ rating. Truist also rated the stock as ‘Buy’.

Analysis of e.l.f. Beauty Inc (ELF)

Further, the quarter-over-quarter increase in sales is 3.58%, showing a positive trend in the upcoming months.

To gain a thorough understanding of e.l.f. Beauty Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of 15.97% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.00, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

It is also very valuable to look at average volume as an indicator of volatility for a stock, and ELF is recording an average volume of 2.82M. On a monthly basis, the volatility of the stock is set at 5.36%, whereas on a weekly basis, it is put at 1.68%, with a loss of -1.83% over the past seven days. Furthermore, long-term investors anticipate a median target price of $125.00, showing growth from the present price of $122.24, which can serve as yet another indication of whether ELF is worth investing in or should be passed over.

How Do You Analyze e.l.f. Beauty Inc Shares?

A leading company in the Household & Personal Products sector, e.l.f. Beauty Inc (ELF) is based in the USA. When comparing e.l.f. Beauty Inc shares with other companies under Consumer Defensive, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 63.65, there is a growth in quarterly earnings of 96.18%.

The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 3.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 107.83% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

ELF shares are owned by institutional investors to the tune of 107.83% at present.

Hot this week

Cytek BioSciences Inc’s results are impressive

While Cytek BioSciences Inc has overperformed by 3.53%, investors...

Did C4 Therapeutics Inc (CCCC) perform well in the last session?

While C4 Therapeutics Inc has overperformed by 6.12%, investors...

Should investors be concerned about Oracle Corp (ORCL)?

While Oracle Corp has overperformed by 3.98%, investors are...

Is Immunocore Holdings plc ADR (IMCR) worth investing in despite its overvalued state?

While Immunocore Holdings plc ADR has overperformed by 2.86%,...

Are Pagerduty Inc (PD) shares a good deal now?

While Pagerduty Inc has overperformed by 2.06%, investors are...

Topics

Cytek BioSciences Inc’s results are impressive

While Cytek BioSciences Inc has overperformed by 3.53%, investors...

Did C4 Therapeutics Inc (CCCC) perform well in the last session?

While C4 Therapeutics Inc has overperformed by 6.12%, investors...

Should investors be concerned about Oracle Corp (ORCL)?

While Oracle Corp has overperformed by 3.98%, investors are...

Is Immunocore Holdings plc ADR (IMCR) worth investing in despite its overvalued state?

While Immunocore Holdings plc ADR has overperformed by 2.86%,...

Are Pagerduty Inc (PD) shares a good deal now?

While Pagerduty Inc has overperformed by 2.06%, investors are...

Root Inc (ROOT) requires closer examination

While Root Inc has overperformed by 2.15%, investors are...

AAON Inc (AAON) shows promising results

While AAON Inc has overperformed by 1.12%, investors are...

What was Sasol Ltd ADR (SSL)’s performance in the last session?

While Sasol Ltd ADR has underperformed by -10.96%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.